2023 Annual Meeting | P8 - Poster Session 8

Date Tuesday 04/25/23

Time 11:45 AM - 12:45 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuro-oncology, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, ��ɫ��, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG), Palliative Care, Practice, Policy, and Ethics

CME Available 0.00 CME credit

Event Timeline
11:45 AM - 12:45 PM EST	Abstract	9-002 - Utilizing Augmented Reality to Quantify Information Processing and Motor Performance in Military Personnel to Detect Mild Traumatic Brain Injury Ryan Kaya, PT
11:45 AM - 12:45 PM EST	Abstract	9-004 - Inter- and Intra-Rater Reliability of a Virtual Concussion Assessment During the Era of the COVID-19 Pandemic Alani Jack
11:45 AM - 12:45 PM EST	Abstract	9-005 - Evaluating Quality of Website-Derived Concussion Information Pierce Brody
11:45 AM - 12:45 PM EST	Abstract	9-006 - Increasing SUR1-related pathway activity with increasing injury severity in immune and neurovascular cells after murine TBI
11:45 AM - 12:45 PM EST	Abstract	9-007 - Delay in Clearance of Labeled Protons in Patients with Acute Head Trauma Utilizing MRI 3D TGSE PASL MRI (Arterial Spin Labeling) Jubin Kang
11:45 AM - 12:45 PM EST	Abstract	9-008 - Synthesis of Behavioral Health Outcomes in Mild Traumatic Brain Injury using Principal Component Analysis (PCA) Teena Shetty, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	9-009 - A Systematic Review of Resting-State fMRI in Traumatic Brain Injury Across Injury Age, Severity, Mechanism, Chronicity, and Imaging Methods Kevin Bickart, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	9-010 - Audit of Guidance on Contraceptive Measures and Folic Acid Supplementation in Women with Epilepsy Emily Feeney
11:45 AM - 12:45 PM EST	Abstract	9-011 - Pregnancy Seizure Outcomes for Epilepsy Patients with Catamenial Seizure Exacerbation Paula E. Voinescu, MD
11:45 AM - 12:45 PM EST	Abstract	9-012 - A Look At Social Disparities in Pregnancy Outcomes in Women With Epilepsy Jasmine S. Coles
11:45 AM - 12:45 PM EST	Abstract	15-002 - Training Neurology Residents to Address Uncomfortable Patient Behavior Through a Simulated Experience Sakinah Sabadia, MD
11:45 AM - 12:45 PM EST	Abstract	15-003 - Teaching Neurology Trainees to Lead a Goals of Care Conversation using Simulation Brandon Giglio, MD
11:45 AM - 12:45 PM EST	Abstract	15-004 - Simulation-based Assessment of Brain Death Determination for ACGME Milestones of Adult Neurology Residents Briana Wasserstrom, DO
11:45 AM - 12:45 PM EST	Abstract	15-005 - A Telehealth Training Program for Neurology Residents Matthew S. Davitz, MD
11:45 AM - 12:45 PM EST	Abstract	15-006 - Resident Perceptions of a Teleneurology Curriculum Shivika Chandra, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	3-001 - Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 after Re-baselining in the Phase 3 EVOLVE-MS-1 Study James D. Bowen, MD
11:45 AM - 12:45 PM EST	Abstract	3-002 - Compliance and Persistence With Ofatumumab Treatment in Patients With Relapsing Multiple Sclerosis in Clinical Trials for Up to 4 Years Enrique Alvarez, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	3-003 - Remibrutinib, a Novel Bruton's Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency In Vitro Bernd C. Kieseier, MD
11:45 AM - 12:45 PM EST	Abstract	3-004 - Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis Jeffrey A. Cohen, MD
11:45 AM - 12:45 PM EST	Abstract	3-005 - A systematic review and meta-analysis of extended interval dosing (EID) vs. standard-interval dosing (SID) of Natalizumab for multiple sclerosis patients. Eslam M. Rabea
11:45 AM - 12:45 PM EST	Abstract	3-006 - The initial reduction in the percentage of peripheral lymphocytes and long disease course are associated with sustained response to Dimethyl Fumarate (DMF) in a small cohort of patients with Relapsing-Remitting Multiple Sclerosis Cristina M. Ramo, MD
11:45 AM - 12:45 PM EST	Abstract	3-007 - New Mitigation Protocol for Alemtuzumab Infusion Related Reactions in a Chilean Cohort Jose Miguel Valdes, MD
11:45 AM - 12:45 PM EST	Abstract	3-008 - Aspirin Precooling Improves Exercise Performance in Multiple Sclerosis: Results of a double-blind randomized controlled trial Victoria Leavitt, PhD, FAAN
11:45 AM - 12:45 PM EST	Abstract	3-009 - Ketogenic Diet Intervention Improves Sleep in Patients with Relapsing Multiple Sclerosis Jacob B. Perlman, MD
11:45 AM - 12:45 PM EST	Abstract	3-010 - Siponimod Stabilizes Physical Disability Scores in People Living With Secondary Progressive Multiple Sclerosis After 2 Years of Treatment: Analysis From the Novartis Global Managed Access Program Gina Mavrikis Cox, PhD
11:45 AM - 12:45 PM EST	Abstract	3-011 - Ocrelizumab and Cladribine had similar EDSS stability and safety profile in patients with highly active multiple sclerosis Fatemah Alshawaf, MD
11:45 AM - 12:45 PM EST	Abstract	3-012 - Evaluating the Effect of Disease Duration in High Efficacy Versus Mid Efficacy Disease Modifying Therapies: Could This Help in Deciding When to De-escalate? Enrique Alvarez, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	3-013 - AMASIA study: Real world insights on the impact of early siponimod treatment on SPMS patients in Germany Olaf Hoffmann, MD
11:45 AM - 12:45 PM EST	Abstract	3-014 - Safety and efficacy of Cladribine in real life sitting, Kuwait Experience Malak AlMojel, MD
11:45 AM - 12:45 PM EST	Abstract	3-015 - Efficacy and Safety Profile of Cladribine Tablets in an Italian Real-Life Cohort of Relapsing-Remitting Multiple Sclerosis Patients: A Monocentric Longitudinal Observational Study Paolo Preziosa
11:45 AM - 12:45 PM EST	Abstract	3-016 - Progressive Multifocal Leukoencephalopathy (PML) With Anti-CD20 and Other Monoclonal Antibody (mAb) Therapies in Multiple Sclerosis Kanika Sharma
11:45 AM - 12:45 PM EST	Abstract	3-017 - Male MS Patients' Safety, Tolerability and Efficacy Outcomes Do Not Differ from Female Patients Treated with Diroximel Fumarate: EVOLVE-MS-1 Ad-hoc Analysis Annette Wundes, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	3-018 - A Case Report: Simultaneous Presentation of Morphea and Multiple Sclerosis, a Diagnostic and Management Challenge. Richa Thakkar, DO
11:45 AM - 12:45 PM EST	Abstract	12-001 - Identifying Neuroimaging Patterns in Mitochondrial Leukoencephalopathies Sonal Sharma, MD
11:45 AM - 12:45 PM EST	Abstract	12-002 - Generative Editing via Convolutional Obscuring (GECO): A Generative Adversarial Network for MRI de-artifacting Bryce Allen Bagley
11:45 AM - 12:45 PM EST	Abstract	12-003 - Radiological features of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and its longitudinal progression Rajasimhan Rajagovindan, PhD
11:45 AM - 12:45 PM EST	Abstract	12-004 - A Multimodal Neuroimaging Feature Extraction Framework for Biomarker Discovery in Myotonic Dystrophies Tahereh Kamali, PhD
11:45 AM - 12:45 PM EST	Abstract	12-005 - A Case Report on the Elusivity of Imaging in Detecting a Ruptured Dermoid Cyst
11:45 AM - 12:45 PM EST	Abstract	12-006 - Neuroimaging in Acute Ethylene Glycol Toxicity James Hiana, MD
11:45 AM - 12:45 PM EST	Abstract	12-007 - Diabetic Striatopathy; A Differential Worth Considering in Diabetic Patients with Acute Onset Hyperkinetic Movements or Basal Ganglia (Striatal) Abnormalities on Imaging. Samuel Durojaye, MD
11:45 AM - 12:45 PM EST	Abstract	6-001 - Lack of Better Functional Outcomes in Young Border Hispanic Patients with Acute Ischemic Stroke after Endovascular Thrombectomy Compared to Older Patients: A Retrospective Chart Review Saisree Ravi, MD
11:45 AM - 12:45 PM EST	Abstract	6-002 - Optimizing Management and Outcomes of Large Vessel Occlusion Ischemic Stroke Utilizing Mobile Stroke Units Muhammad Bilal Tariq, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-004 - The BAND score: a simple upfront predictive model for futile recanalization to guide patient selection for endovascular thrombectomy during acute ischemic stroke triage Huanwen Chen, MD
11:45 AM - 12:45 PM EST	Abstract	6-005 - Tenecteplase Versus Alteplase for Acute Ischemic Stroke in a Community Hospital Setting Latha Ganti, MD, MS, MBA, FACEP
11:45 AM - 12:45 PM EST	Abstract	6-006 - Patterns in the Number of Interventionalists for Endovascular Treatment of Acute Ischemic Stroke in the US Ankita Tripathi, MD
11:45 AM - 12:45 PM EST	Abstract	6-008 - Intra-Arterial Thrombolysis Associated with Symptomatic Intracranial Hemorrhage in Acute Basilar Artery Thrombectomy, PC-SEARCH Registry Analysis Adam T. Mierzwa, MD
11:45 AM - 12:45 PM EST	Abstract	6-009 - Stenting Plus Medical Therapy versus Medical Therapy Alone in Patients With Symptomatic Intracranial Stenosis: A Systematic Review and Meta-Analysis Artur Menegaz de Almeida, MS
11:45 AM - 12:45 PM EST	Abstract	6-010 - Real World Experience with Viz.ai Automated Large Vessel Occlusion in CT Angiogram Nick Mannix, MD
11:45 AM - 12:45 PM EST	Abstract	6-011 - Improving Thrombectomy Times Utilizing Stroke Transfer Coordinators Jessica D. Lee, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	6-012 - Predictors of Functional Recovery after Mechanical Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation Milagros Galecio-Castillo, MD
11:45 AM - 12:45 PM EST	Abstract	6-013 - Quality and Outcomes Following Implementation of Anesthesiology for all Mechanical Thrombectomy Cases Madison McGann
11:45 AM - 12:45 PM EST	Abstract	6-014 - Pre-morbid Risk Factor Control Differences by Age in Patients Undergoing Thrombectomy for Acute Ischemic Stroke Kathryn Grimes, MD
11:45 AM - 12:45 PM EST	Abstract	6-015 - Acute Ischemic Stroke Large Vessel Occlusion treated with Mechanical Thrombectomy in the Pediatric Populatio Jessica Glenn, NP
11:45 AM - 12:45 PM EST	Abstract	6-016 - Acute loading dose of antiplanets before Stent-assisted repair of cerebral aneurysm associated with reduced ischemic events and good outcomes Yahia M. Lodi, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	6-017 - Intravenous Thrombolysis followed by Endovascular Thrombectomy compared with Direct Endovascular Thrombectomy for Stroke: a Systematic Review and Meta-analysis of Randomized and Non-Randomized Studies Bakhtawar Ahmad, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-018 - Comparison of Tele-stroke transfer between intervention and non-intervention cases and 30-day outcome events Shravan Sivakumar, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-019 - Area Deprivation Index (ADI) and Median Income Associations with Clinical Outcomes of Endovascular Therapy for ACLVO stroke Murat Sari, MD
11:45 AM - 12:45 PM EST	Abstract	6-020 - Indications and Outcomes of Carotid Artery Stenting among Consecutive Patients over Age 70 at The Ottawa Hospital, a Comprehensive Stroke Centre in Ontario, Canada Holly Sim, MD
11:45 AM - 12:45 PM EST	Abstract	6-021 - Effect of Stroke Etiology on Mechanical Thrombectomy Outcomes in Young Adults: A Retrospective Data Analysis Kriti Bhayana, MD
11:45 AM - 12:45 PM EST	Abstract	6-022 - Examining Predictors of Favorable 90-day Outcome in Stroke Patients with Active Cancer Undergoing Endovascular Therapy Yasaman Pirahanchi, MD
11:45 AM - 12:45 PM EST	Abstract	6-023 - Osteoarthritis is associated with lower likelihood of receiving stroke thrombectomy despite similar post-thrombectomy outcomes: a national study Huanwen Chen, MD
11:45 AM - 12:45 PM EST	Abstract	6-024 - Onyx© Embolization of Dural Arteriovenous Fistulae at the Cranio-Cervical Junction Khaled Gharaibeh, MD
11:45 AM - 12:45 PM EST	Abstract	6-025 - Lack of Pre-treatment Thrombolysis and Low ASPECTS are Associated with Poor Rates of Recanalization After Mechanical Thrombectomy Muhammad M. Alvi, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	6-026 - Bilateral Middle Meningeal Artery Embolization and Resection of a Large Parafalcine Meningioma: a Case Study Melinda C. Arthur, DO
11:45 AM - 12:45 PM EST	Abstract	6-027 - Successful Prevention of Bow Hunter's Stroke Associated with Rheumatoid Atlantoaxial Subluxation via Coil Occlusion Ryoichi Inoue, MD
11:45 AM - 12:45 PM EST	Abstract	6-028 - Recanalized paramedian thalamoperforators after intraarterial tirofiban treatment in a patient with bilateral fetal-type PCAs Minyoul Baik, Jr., MD
11:45 AM - 12:45 PM EST	Abstract	6-029 - Large Vessel Occlusion Related Ischemic Stroke From Vitamin B12-Deficiency Related Homocysteine Shruthi Harish, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-030 - Anterior Cerebral Artery Associated “Limb-Shaking TIA” A3 Branch Stenosis Corrected With Submaximal Intracranial Angioplasty Kholoud Altarazi, MD
11:45 AM - 12:45 PM EST	Abstract	6-031 - Foreign Body Reaction After Endovascular Treatment with Pipeline Embolization Device Ma Su Su Aung, MD
11:45 AM - 12:45 PM EST	Abstract	7-001 - Amyotrophic Lateral Sclerosis and Aid-in-Dying: Describing and Comparing ALS Patients Requesting Physician-Assisted Death with Patients Dying Directly of ALS in the Hospital Setting Pierre Trudel
11:45 AM - 12:45 PM EST	Abstract	7-002 - Simulation training in Neuropalliative Care Rakhee Lalla, DO
11:45 AM - 12:45 PM EST	Abstract	7-003 - Palliative and end-of-life care in Parkinson’s disease : a survey of patients’ perceptions and knowledge in France Manon Auffret, PhD, PharmD, DAAN
11:45 AM - 12:45 PM EST	Abstract	7-004 - Are Neurologists Aware of the Neurology-Specific Hospice Criteria? Daniel M. Oh, MD
11:45 AM - 12:45 PM EST	Abstract	7-005 - Palliative Care Knowledge and Attitudes among Patients with Neurodemyelinating Diseases Aliza B. Ben-Zacharia, PhD, DNP, ANP, FAAN
11:45 AM - 12:45 PM EST	Abstract	7-006 - Outpatient Palliative Care for Parkinson’s Disease: Results from a National Survey Kei Sugiura, MD
11:45 AM - 12:45 PM EST	Abstract	7-007 - Clinical Outcomes From a Phase 2, Open-Label Study of NE3107 in Patients With Cognitive Decline Due to Degenerative Dementias Kaya G. Jordan, CRC
11:45 AM - 12:45 PM EST	Abstract	7-008 - Allopregnanolone as a Regenerative Therapeutic for Alzheimer’s Disease (AD): A phase 2 proof-of-concept clinical trial using hippocampal volume as a surrogate endpoint Gerson D. Hernandez Rivera, MD, MPH
11:45 AM - 12:45 PM EST	Abstract	7-009 - A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Donepezil Transdermal Delivery System Alan Blau, PhD
11:45 AM - 12:45 PM EST	Abstract	7-010 - A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Effects of SAGE-718 in Patients with Alzheimer's Disease: Study Design Tiffany Lago, MD
11:45 AM - 12:45 PM EST	Abstract	1-001 - EEG Characteristics of Mortality in Patients with Altered Mental Status and Seizures: A Matched Case-Control Study Rizk Alghorazi
11:45 AM - 12:45 PM EST	Abstract	1-002 - Anti-seizure Medication Use and Outcomes in Older Adults with Acute Traumatic Brain Injury Poojith Nuthalapati, MD
11:45 AM - 12:45 PM EST	Abstract	1-003 - The Utilization of the Ketogenic Diet for Adults with Status Epilepticus Fernanda Jacinto Pereira Teixeira, MD
11:45 AM - 12:45 PM EST	Abstract	1-004 - A Modern Artillery to put off the Electric Storm of the Brain– A case report of aborting seizure with brivaracetam 2-minute intravenous bolus in a patient with a compromised airway. Maycky Tang, DO
11:45 AM - 12:45 PM EST	Abstract	1-005 - High-Dose Levetiracetam: A Novel Post-Arrest Anti-Arrhythmic Medication? Eric Stulberg, MD
11:45 AM - 12:45 PM EST	Abstract	1-006 - Evaluating Barriers and Tools to Optimize Resident Call Scheduling on Neurology In-Patient Services James Im, MD
11:45 AM - 12:45 PM EST	Abstract	10-001 - Is ALS Onset Accelerated by Chloroviruses and Delayed by Antiviral Immune Responses? Gary L. Pattee, MD
11:45 AM - 12:45 PM EST	Abstract	10-002 - ALS Causative Mutations in KIF5A Disrupt Autoinhibition Leading to Toxic Gain of Function Jonathan R. Brent, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	10-003 - At-Home Telespirometry [AHT] in Amyotrophic Lateral Sclerosis [ALS] Eufrosina I. Young, MD
11:45 AM - 12:45 PM EST	Abstract	10-004 - Evidence for Survival Benefit in ALS with CNM-Au8 Treatment Across Three Study Populations James D. Berry, MD MPH
11:45 AM - 12:45 PM EST	Abstract	10-005 - Quantification of HLA Allele and Haplotype Frequencies in ALS and ALS-FTD Darshan Pandya, MD
11:45 AM - 12:45 PM EST	Abstract	10-006 - The role of systemic immunity in ALS: a population-based study Maurizio Grassano, MD
11:45 AM - 12:45 PM EST	Abstract	10-007 - Small Molecule Positive Modulator of Hepatocyte Growth Factor (HGF)/MET, ATH-1105, Improves Function and Reduces Disease Biomarkers in a TDP-43 Mouse Model of Amyotrophic Lateral Sclerosis Jewel Johnston
11:45 AM - 12:45 PM EST	Abstract	10-008 - Objective Measures of Gait Changes in ALS Correlate with Functional Rating Scale Marcell P. Szabo
11:45 AM - 12:45 PM EST	Abstract	10-009 - At-Home Telespirometry (AHT) In ALS Implementation Science: Different Patient Rates of Erect Forced Vital Capacity (eFVC) 3 percent predicted (%p) Drops per Month in Two ALS Populations with Different Baseline Rates of NIV Utilization Benjamin R. Brooks, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	10-010 - The Integrated Stress Response Is Modulated by eIF2B Agonist DNL343: Results From Phase 1 Healthy Subject and Phase 1b ALS Patient Studies. Linus D. Sun, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	10-011 - A 40-week Phase 2B Randomized, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Memantine in Amyotrophic Lateral Sclerosis Salman Bhai, MD
11:45 AM - 12:45 PM EST	Abstract	10-013 - MicroRNA Expression in ALS: A Systematic Review and Bioinformatic Analysis María Paula Aguilera Peña, MD
11:45 AM - 12:45 PM EST	Abstract	10-014 - Introduction of Quantitative Scale for Fasciculations in ALS Patients Cecilia Quarracino Benchetrit, MD
11:45 AM - 12:45 PM EST	Abstract	10-015 - Seronegative Isaac Syndrome Presenting as Focal Limb Stiffness Responsive to Plasma Exchange Therapy Nadia Khalil, MD
11:45 AM - 12:45 PM EST	Abstract	4-001 - Sex and Gender Differences Influence Urinary Symptoms and Management in Multiple System Atrophy Elke Schipani, MD
11:45 AM - 12:45 PM EST	Abstract	4-002 - Wearable Sensors for Quantitative Motor Assessments in Multiple System Atrophy Daniel O. Claassen, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	4-003 - Patient Concept Elicitation Interviews: Insights into Multiple System Atrophy (MSA) Patient Experiences and Relevance of a modified United Multiple System Atrophy Rating Scale Michele Potashman, PhD
11:45 AM - 12:45 PM EST	Abstract	4-004 - Application of Phosphorylated Alpha Synuclein (p-syn) Skin Biopsy in Clinical Practice: Audit at an Academic Medical Center Cheng Chin Wang, DO
11:45 AM - 12:45 PM EST	Abstract	4-005 - Dysautonomia symptoms and quality of life in non-hospitalized neurology outpatients with post-acute sequelae of COVID-19 Samarah Ahmed
11:45 AM - 12:45 PM EST	Abstract	4-006 - A Case of Autonomic Failure in Superficial Siderosis Bridget Ollesch, MD
11:45 AM - 12:45 PM EST	Abstract	4-007 - Peripheral sudomotor abnormalities in postural tachycardia syndrome (POTS) Anna Newman
11:45 AM - 12:45 PM EST	Abstract	4-008 - Botulinum toxin for Sialorrhea in Patients with Parkinson’s disease & Atypical Parkinsonism: A Single Center Real-World Study Danyaal Buttar
11:45 AM - 12:45 PM EST	Abstract	4-009 - Adverse Childhood Experiences Are Associated with Seizures in Children: A Cross-Sectional Analysis Marissa Anto, MD
11:45 AM - 12:45 PM EST	Abstract	4-010 - Distinguishing TLE and TLE+ using magnetoencephalography virtual sensors Joanna Hong
11:45 AM - 12:45 PM EST	Abstract	4-011 - PRAX-562-101: A Phase 1 Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of PRAX-562 in Healthy Volunteers Brian Pfister
11:45 AM - 12:45 PM EST	Abstract	4-012 - PRAX-628: A Novel Sodium Channel Blocker with Greater Potency and Activity Dependence Compared to Standard of Care Kris Kahlig, PhD
11:45 AM - 12:45 PM EST	Abstract	13-001 - Adult-Onset Acute Flaccid Myelitis with White Matter-predominant Longitudinally Extensive Transverse Myelitis Following Coxsackie B5 Enterovirus Infection: a case report Olga Manouvakhova, MD
11:45 AM - 12:45 PM EST	Abstract	13-002 - A Case Report of Parainfectious Opsoclonus-Myoclonus Syndrome after Powassan Virus Meningitis Stephanie Syc-Mazurek, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	13-003 - Subacute Development of Parkinsonism as a Clinical Manifestation of Powassan Virus Neuroinvasive Disease Clifton Lewis, DO
11:45 AM - 12:45 PM EST	Abstract	13-004 - Concomitant West Nile Virus Encephalitis and Ischemic Strokes – A Case Report and Review of the Literature. Karan Hingorani, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	13-005 - A Retrospective Review on Encephalitis in the University of Colorado Health Care System and a Proposed Diagnostic Approach Madeline Garza, MD
11:45 AM - 12:45 PM EST	Abstract	13-006 - What’s the Cure for These Hiccups?: A Case of Area Postrema Syndrome due to Ventriculitis Audrey Wadood, MD
11:45 AM - 12:45 PM EST	Abstract	13-007 - A Case of Blood Culture-Negative Infective Endocarditis Presenting as Recurrent Ischemic Stroke Sydney Chatfield, MD
11:45 AM - 12:45 PM EST	Abstract	5-001 - Perry syndrome – the genetic, clinical, and pathological characteristics of the disease Jaroslaw Dulski, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	5-002 - Rate of Change of Pons and Middle Cerebellar Peduncle Diameters is Diagnostic of Multiple System Atrophy of the Cerebellar Type (MSA-C) Christopher D. Stephen, MB ChB, FRCP, MSc, SM
11:45 AM - 12:45 PM EST	Abstract	5-003 - Sex Differences for Verbal Fluency Decline in Progressive Supranuclear Palsy Leonardino Digma, MD
11:45 AM - 12:45 PM EST	Abstract	5-004 - Effect of APOE e4 genotype on age at onset and comorbid pathologies in multiple system atrophy Hiroaki Sekiya, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	5-005 - Characteristics and Outcome of Patients with Young-Onset Multiple System Atrophy Negin Badihian, MD
11:45 AM - 12:45 PM EST	Abstract	5-006 - Predictors of Survival in Atypical Parkinsonian Syndromes in a Tunisian Cohort Amina Nasri, MD
11:45 AM - 12:45 PM EST	Abstract	5-007 - Longitudinal free-water changes in dementia with Lewy bodies Shannon Y. Chiu, MD, MSc
11:45 AM - 12:45 PM EST	Abstract	5-009 - Retrospective Review of Amantadine Use in Progressive Supranuclear Palsy Nikolaus McFarland, MD, PhD, FAAN
11:45 AM - 12:45 PM EST	Abstract	5-010 - Who Should Answer? How to Assess Psychosis in Demented Patients with Parkinson’s Disease or Lewy Body Dementia. Blake Beehler, MD
11:45 AM - 12:45 PM EST	Abstract	5-011 - Efficacy of Omaveloxolone in Friedreich’s Ataxia: Post-Hoc Analysis Using Global Statistics Test to Strengthen Secondary Endpoint Analyses Suzanne Hendrix, PhD
11:45 AM - 12:45 PM EST	Abstract	5-012 - Somatosensory evoked potentials in spinocerebellar ataxias type 3 and 10: Preliminary data Leo Coutinho, MD
11:45 AM - 12:45 PM EST	Abstract	5-013 - Anti-Ma2 Antibody Paraneoplastic Cerebellar Degeneration Associated with Renal Cell Carcinoma: A Case Report. Nada Ahmed, MD
11:45 AM - 12:45 PM EST	Abstract	5-014 - Cala Trio wrist-worn medical device for tremor improvement in patient with Spinocerebellar Ataxia-12 Syed Mehdi Husaini, MD
11:45 AM - 12:45 PM EST	Abstract	5-015 - Intrafamilial Heterogeneity in Spinocerebellar Ataxia Type 21 Emma L. Wetmore, MD
11:45 AM - 12:45 PM EST	Abstract	5-016 - Rapidly Progressive Cerebellar Ataxia and Dementia due to Cortical Cerebellar and Thalamic Degeneration: A Case Series of Two Autopsy Confirmed Patients Shunsuke Koga, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	5-017 - Subgroup Analyses of Effect of Treatment With Levodopa Inhalation Powder (CVT-301) 84mg by Severity of OFF Symptoms in People with Parkinson’s Disease, as Assessed by the Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) Ron Cohen, MD
11:45 AM - 12:45 PM EST	Abstract	2-001 - Impact of Updates in Headache Quality Measures on Adherence to Best Practices in a Neurology Resident Clinic Robert H. Cascella
11:45 AM - 12:45 PM EST	Abstract	2-002 - A Machine Learning Model Including Questionnaire and Structural Imaging Data Predicts Headache Improvement in Patients with Acute Post-traumatic Headache Attributed to Mild Traumatic Brain Injury Catherine D. Chong, PhD, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-003 - Development and validation of a novel model for characterizing migraine outcomes within electronic health records utilizing artificial intelligence Carlton Anderson, PhD
11:45 AM - 12:45 PM EST	Abstract	2-004 - Brain volume changes associated with the recurrence of spontaneous intracranial hypotension after epidural blood patch Sun Ju Chung, MD, PhD, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-005 - Clinician Perspectives on Remote Monitoring for Patients with Headache Disorders Aarti R. Katara
11:45 AM - 12:45 PM EST	Abstract	2-006 - Asynchronous Telemedicine Platform Associated with Decreased Migraine-Related Emergency Room and Urgent Care Use Sara C. Crystal, MD
11:45 AM - 12:45 PM EST	Abstract	2-007 - Psychometric Evaluation of the Migraine-Specific Quality of Life Questionnaire (MSQ v2.1) Using Data From Phase 3 Clinical Trials in Patients With Chronic Migraine (CM) and Episodic Migraine (EM) Krutika Jariwala-Parikh, PhD
11:45 AM - 12:45 PM EST	Abstract	2-008 - Psychometric Evaluation of the Activity Impairment in Migraine-Diary (AIM-D) Using Data From a Phase 3 (PROGRESS) Clinical Trial in Patients With Chronic Migraine Krutika Jariwala-Parikh, PhD
11:45 AM - 12:45 PM EST	Abstract	2-009 - A Telemedicine Platform to Increase Access to Migraine Care in Men Sara C. Crystal, MD
11:45 AM - 12:45 PM EST	Abstract	2-010 - Patient-identified most bothersome symptom as a driver of health-related quality of life experienced by patients with migraine Peter Goadsby, MD, PhD, FRS
11:45 AM - 12:45 PM EST	Abstract	2-011 - CME-Certified Microlearning Platform Successful in Improving Knowledge on the Use of Preventive Migraine Therapies Among Neurologists and PCPs Thomas Finnegan, Jr., PhD
11:45 AM - 12:45 PM EST	Abstract	2-012 - Circulating microRNAs in migraine patients: Systematic review and bioinformatic analysis. María Paula Aguilera Peña, MD
11:45 AM - 12:45 PM EST	Abstract	11-001 - Economic Impact of a Multidisciplinary Neurofibromatosis Clinic in a Canadian Tertiary Care Hospital Julien Rousseau, MD, CM
11:45 AM - 12:45 PM EST	Abstract	11-003 - Growth of Angiomyolipomas in Patients with Tuberous Sclerosis Complex Treated with mTOR Inhibitor Differs by Indication for Treatment Lauren A. Neal
11:45 AM - 12:45 PM EST	Abstract	11-004 - Identifying Lesions of the Corpus Callosum in Patients with Neurofibromatosis Type I Nora R. Jandhyala, MD

Faculty Disclosures
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Gene Y. Sung, MD, MPH	The institution of Dr. Sung has received research support from NIH.
Seemant Chaturvedi, MD, FAHA, FAAN	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Neil A. Busis, MD, FAAN	Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ��. Dr. Busis has received personal compensation in the range of $0-$499 for serving as a Consultant for American Medical Association. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Mark B. Bromberg, MD, PhD, FAAN	Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received personal compensation in the range of $10,000-$49,999 for serving as a Medical reviewer with Department of Justice, Vaccination Compensation Board.
Kathleen B. Digre, MD, FAAN	Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care.
Horacio C. Kaufmann, MD, FAAN	Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Alan M. Rapoport, MD, FAAN	Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie, Amgen, Biohaven, Cala Health, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews.
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical ��ɫ�� Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with ��ɫ�� that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Peter Goadsby, MD, PhD, FRS	Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Jeremy M. Shefner, MD, PhD, FAAN	Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $0-$499 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuvivo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nura BIo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a grant review chair with DOD- General Dynamics.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Russell E. Bartt, MD, FAAN	Dr. Bartt has nothing to disclose.
Gary L. Pattee, MD	The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
James C. Grotta, MD, FAAN	Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Phillip A. Low, MD, FAAN	Dr. Low has nothing to disclose.
Elijah Stommel, MD, FAAN	Dr. Stommel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Suslick Attorney. The institution of Dr. Stommel has received research support from CDC.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Alexander A. Mauskop, MD, FAAN	Dr. Mauskop has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lily. Dr. Mauskop has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Merit E. Cudkowicz, MD, MSC, FAAN	Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Anne H. Cross, MD, FAAN	Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Irene Litvan, MD, FAAN	Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
Eduardo E. Benarroch, MD, FAAN	Dr. Benarroch has nothing to disclose.
Steven Vernino, MD, PhD, FAAN	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Scott D. Eggers, MD	Dr. Eggers has received publishing royalties from a publication relating to health care.
Nancy Fischbein, MD	Dr. Fischbein has received publishing royalties from a publication relating to health care.
Bernard M. Ravina, MD, MSCE	Dr. Ravina has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Ravina has stock in Praxis.
Vivien H. Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Wolfgang Singer, MD, FAAN	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
John Corboy, MD, FAAN	Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Myla D. Goldman, MD, MSc, FAAN	Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniska. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., . Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Goldman has received personal compensation in the range of $0-$499 for serving as a Grant Review Committee Member with Department of Defense.
Robert Cowan, MD, FAAN	Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Dennis W. Dickson, MD	Dr. Dickson has nothing to disclose.
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Mark S. Freedman, MD, FAAN	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Mandip S. Dhamoon, MD, MPH	Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Jacinda B. Sampson, MD, PhD	Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Thanh Nguyen, MD	Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vesalio. Dr. Nguyen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Nguyen has received research support from Boston Medical Center. The institution of Dr. Nguyen has received research support from Society of Vascular and Interventional Neurology.
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.
Otto Hernandez Fustes, MD, PhD, FAAN	Dr. Hernandez Fustes has nothing to disclose.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Benzi Kluger, MD, FAAN	Dr. Kluger has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Neuropalliative Care Society. Dr. Kluger has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Palliative Medicine. The institution of Dr. Kluger has received research support from NIH. The institution of Dr. Kluger has received research support from PCORI.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Teena Shetty, MD, FAAN	Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.
Sun Ju Chung, MD, PhD, FAAN	Dr. Chung has nothing to disclose.
Helio Afonso G. Teive, MD, PhD, FAAN	Dr. Teive has nothing to disclose.
James H. Bower, MD, MSc, FAAN	The institution of Dr. Bower has received research support from Abbvie.
Todd J. Schwedt, MD, FAAN	Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Schwedt has or had stock in Nocira.Dr. Schwedt has or had stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. The institution of Dr. Schwedt has received research support from AbbVie. The institution of Dr. Schwedt has received research support from Flinn Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Nicolas Dupre, MD, FAAN	Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Cristina Moglia	Cristina Moglia has nothing to disclose.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Jan Claassen, MD, PhD	Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Yahia M. Lodi, MD, FAAN	Dr. Lodi has nothing to disclose.
Sheldon E. Jordan, MD	Dr. Jordan has stock in Synaptec Network.
Petr Kanovsky, PhD	Dr. Kanovsky has nothing to disclose.
Brian Silver, MD, FAAN	Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
James D. Bowen, MD	Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
Syed F. Zaidi, MD	Dr. Zaidi has nothing to disclose.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
John W. Lindsey, MD	Dr. Lindsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Lindsey has received research support from TG Therapeutics. The institution of Dr. Lindsey has received research support from CDMRP.
Werner Poewe, MD	Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Colin Doherty, MD	The institution of Dr. Doherty has received research support from UCB pharma. The institution of Dr. Doherty has received research support from Science foundation Ireland.
Mustafa S. Siddiqui, MD, FAAN	Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Owen A. Ross, PhD	Dr. Ross has nothing to disclose.
Jane Boggs, MD	The institution of Dr. Boggs has received research support from Liva Nova. Dr. Boggs has a non-compensated relationship as a Chairman PAB with Epilepsy Alliance North Carolina that is relevant to AAN interests or activities.
Suzanne Hendrix, PhD	Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
	No disclosure on file
Jennifer S. Hui, MD	Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Hui has received research support from Roche. The institution of Dr. Hui has received research support from Abbvie. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Roundtable speaker with Medscape .
Jessica D. Lee, MD, FAAN	Dr. Lee has received personal compensation for serving as an employee of ��ɫ��. The institution of Dr. Lee has received research support from Janssen.
Robert P. Bowser, PhD	An immediate family member of Dr. Bowser has received personal compensation for serving as an employee of nVector, Inc.. Dr. Bowser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MT Pharma USA. Dr. Bowser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Therapeutics. Dr. Bowser has or had stock in nVector.Dr. Bowser has received intellectual property interests from a discovery or technology relating to health care.
Han-Xiang Deng, MD	Dr. Deng has nothing to disclose.
Leonard van den Berg, MD	The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Melissa Armstrong, MD, MSc, FAAN	The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Vicki Shanker, MD, FAAN	Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Justin Y. Kwan, MD, FAAN	Dr. Kwan has received research support from National Institutes of Health. Dr. Kwan has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with National Institutes of Health.
Todd D. Levine, MD	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Warren D. Lo, MD, FAAN	The institution of Dr. Lo has received research support from NIH. Dr. Lo has received publishing royalties from a publication relating to health care.
Steven K. Feske, MD	Dr. Feske has received publishing royalties from a publication relating to health care.
Lon Schneider, MD	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immue. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athira. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha-cognition. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortexyme. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Ltd. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Eli Lilly. The institution of Dr. Schneider has received research support from Biogen. The institution of Dr. Schneider has received research support from Biohaven.
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Ron Cohen, MD	Dr. Cohen has received personal compensation for serving as an employee of Acorda Therapeutics. Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for VBL Therapeutics. Dr. Cohen has stock in Acorda Therapeutics.
Robert L. Glanzman, MD, FAAN	Dr. Glanzman has received personal compensation for serving as an employee of Clene Nanomedicine Inc. Dr. Glanzman has stock in Clene Nanomedicine Inc .
Joel Stein, MD	Dr. Stein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Stein has received personal compensation in the range of $0-$499 for serving as a Consultant for Dessintey. Dr. Stein has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. The institution of Dr. Stein has received research support from BrainQ. The institution of Dr. Stein has received research support from Microtransponder.
John W. Day, MD, PhD	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PepGen. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epirium Bio. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Astellas Pharma. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. The institution of Dr. Day has received research support from AMO Pharma. The institution of Dr. Day has received research support from AnnJi. Dr. Day has received research support from CureSMA. The institution of Dr. Day has received research support from Muscular Dystrophy Association. The institution of Dr. Day has received research support from Ionis Pharmaceuticals. The institution of Dr. Day has received research support from NMD Pharma. The institution of Dr. Day has received research support from SMA Foundation. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Florian Then Bergh, MD	Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actelion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fresenius. Dr. Then Bergh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. The institution of Dr. Then Bergh has received research support from Actelion. The institution of Dr. Then Bergh has received research support from Novartis. The institution of Dr. Then Bergh has received research support from DFG (German Science Fund). The institution of Dr. Then Bergh has received research support from Fresenius. The institution of Dr. Then Bergh has received research support from Diamed. Dr. Then Bergh has received personal compensation in the range of $10,000-$49,999 for serving as a Member of the Institutional Ethics Board with University of Leipzig, Medical Faculty.
Latha Ganti, MD, MS, MBA, FACEP	Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Muhammad S. Hussain, MD	Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Mackenzie Cervenka, MD	Dr. Cervenka has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nutricia. Dr. Cervenka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle Health Science/Vitaflo. The institution of Dr. Cervenka has received research support from Nestle Health Science/Vitaflo. Dr. Cervenka has received publishing royalties from a publication relating to health care.
Jinsy Andrews, MD, FAAN	Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Regeneron. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Meyer Squibb. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . The institution of Dr. Andrews has received research support from ALS Platform Trial . The institution of Dr. Andrews has received research support from Corcept.
David R. Lynch, MD, PhD	The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care.
Samuel F. Hunter, MD, PhD	The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Sara C. Crystal, MD	Dr. Crystal has received personal compensation for serving as an employee of Thirty Madison. Dr. Crystal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Crystal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Marc Verin	Mr. Verin has nothing to disclose.
Adam B. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thirty Madison. Dr. Cohen has received stock or an ownership interest from Thirty Madison.
Gabor Toth, MD	Dr. Toth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Toth has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Toth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kaneka. Dr. Toth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra.
Mouhammad A. Jumaa, MD	Dr. Jumaa has nothing to disclose.
Rashmi B. Halker Singh, MD, FAAN	Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Nils Henninger, MD, PhD, FANA, FWSO	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.
Jason MacMore	Jason MacMore has nothing to disclose.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Herbert Schreiber	Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Alexander Sherman	The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Audrey Strongosky	No disclosure on file
Maryna Skliut, MD	Dr. Skliut has nothing to disclose.
Nicholas J. Maragakis, MD, FAAN	Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UptoDate. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharmaceuticals. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. An immediate family member of Dr. Maragakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Basketball Association. Dr. Maragakis has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Akava. An immediate family member of Dr. Maragakis has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Johns Hopkins Howard County Medical Center. Dr. Maragakis has stock in Akava. The institution of Dr. Maragakis has received research support from NIH/NINDS. The institution of Dr. Maragakis has received research support from Department of Defense. The institution of Dr. Maragakis has received research support from Maryland Stem Cell Research Fund. Dr. Maragakis has received intellectual property interests from a discovery or technology relating to health care.
Klaus Seppi, MD	Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO . Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Seppi has received research support from MJFF. The institution of Dr. Seppi has received research support from EU. The institution of Dr. Seppi has received research support from FWF Austrian Science Fund,.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Huw R. Morris, MD, PhD	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities.
Perla C. Thulin, MD	Dr. Thulin has nothing to disclose.
Annette Wundes, MD, FAAN	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Mia T. Minen, MD, FAAN	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Ryosuke Takahashi, MD	Dr. Takahashi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kan Institute. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharma. Dr. Takahashi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ono Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenix. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnyrum. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo Pharma. The institution of Dr. Takahashi has received research support from MEXT. Japan. The institution of Dr. Takahashi has received research support from AMED, Japan. The institution of Dr. Takahashi has received research support from JST, Japan. The institution of Dr. Takahashi has received research support from MHLW, Japan. The institution of Dr. Takahashi has received research support from Sumitomo Pharma. The institution of Dr. Takahashi has received research support from Takeda Pharma. The institution of Dr. Takahashi has received research support from Otsuka Pharma. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a PO with AMED, Japan. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a PO with JST, Japan.
Gian D. Pal, MD	Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm.
Amanda Jagolino-Cole, MD, FAAN	Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� - Neurology Clinical Practice Journal. .
Sara B. Mitchell, MD	Dr. Mitchell has nothing to disclose.
Sohum Desai	Mr. Desai has nothing to disclose.
Paul S. Giacomini, MD	Dr. Giacomini has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Innodem Neurosciences. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for F. Hoffmann- La Roche. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann-La Roche. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffman-La Roche. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi.
Imen Kacem, MD	Dr. Kacem has nothing to disclose.
Peggy Auinger	Ms. Auinger has nothing to disclose.
Amit Kansara, MD	Dr. Kansara has nothing to disclose.
Letizia Mazzini	No disclosure on file
Robert T. Naismith, MD, FAAN	Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Stephanie Syc-Mazurek, MD, PhD	Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Sujata P. Thawani, MD	Dr. Thawani has nothing to disclose.
Richard M. Tsai, MD	Dr. Tsai has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Tsai has stock in Denali Therapeutics.
Cristina M. Ramo, MD	Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANDOZ. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ramo has received research support from HORIZON-2020. The institution of Dr. Ramo has received research support from fis (SPANISH GOVERNMENT). The institution of Dr. Ramo has received research support from BIOGEN. The institution of Dr. Ramo has received research support from MERCK. The institution of Dr. Ramo has received research support from ALMIRALL. The institution of Dr. Ramo has received research support from NOVARTIS. The institution of Dr. Ramo has received research support from RICORS (Spanish Government). The institution of Dr. Ramo has received research support from ROCHE. Dr. Ramo has received publishing royalties from a publication relating to health care.
Francesco Sacca, MD, FAAN	Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Michel C. Shamy, MD	Dr. Shamy has nothing to disclose.
Elizabeth Finger, MD, FAAN	Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. The institution of Dr. Finger has received research support from CIHR. The institution of Dr. Finger has received research support from Physician Servcices Incorporated. The institution of Dr. Finger has received research support from Weston Foundation. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Annual Meeting Course Director with ��ɫ��.
Soojin Park, MD	Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health.
Charles Kassardjian, MD, FAAN	Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Sachin Agarwal, MD, MPH	Dr. Agarwal has nothing to disclose.
Jay L. Alberts, PhD	Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceraxis. Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceraxis. The institution of Dr. Alberts has received research support from NIH. The institution of Dr. Alberts has received research support from Department of Defense. The institution of Dr. Alberts has received research support from Michael J. Fox Foundation. Dr. Alberts has received intellectual property interests from a discovery or technology relating to health care. Dr. Alberts has received personal compensation in the range of $500-$4,999 for serving as a Member, Health and Wellness Council with Peloton Interactive.
Lori Chibnik	No disclosure on file
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Melissa M. Cortez, DO	The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Urvi G. Desai, MD, FAAN	Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Ameer Hassan, DO	Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Ruchira M. Jha, MD	Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Michael Phipps, MD, MHS, FAAN	Dr. Phipps has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMJ.
David A. Stamler, MD	Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics.
Tamela Stuchiner	Ms. Stuchiner has nothing to disclose.
Ashutosh P. Jadhav, MD, FAAN	Dr. Jadhav has nothing to disclose.
Nikolaus McFarland, MD, PhD, FAAN	Dr. McFarland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sutter Health. Dr. McFarland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceuticals. Dr. McFarland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. McFarland has received research support from NIH, Michael J. Fox Foundation, Huntington Disease Society for America, CurePSP, and Mission MSA.. Dr. McFarland has received publishing royalties from a publication relating to health care.
Page B. Pennell, MD, FAAN	The institution of Dr. Pennell has received research support from NIH.
Umer Akbar, MD	Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Matthew D. Troyer, MD	Dr. Troyer has received personal compensation for serving as an employee of Denali Therapeutics Inc. Dr. Troyer has stock in Denali Therapeutics Inc. Dr. Troyer has stock in Merck & Co., Inc. Dr. Troyer has stock in Eli Lilly.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Katharina M. Busl, MD, MS, FAAN	Dr. Busl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rissman Law. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huffman Powell Baley. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University Science. Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SCCM. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Assistant Editor with Neurocritical Care that is relevant to AAN interests or activities.
Wondwossen G. Tekle, MD	Dr. Tekle has nothing to disclose.
Brian Edlow, MD	Dr. Edlow has received research support from NIH.
Matthew Swan, MD, FAAN	The institution of Dr. Swan has received research support from Biogen. The institution of Dr. Swan has received research support from Sage Therapeutics. The institution of Dr. Swan has received research support from Parkinson's Foundation. The institution of Dr. Swan has received research support from Photopharmics. The institution of Dr. Swan has received research support from Denali Therapeutics. The institution of Dr. Swan has received research support from NOEMA Pharma.
Alexandra L. Czap, MD	The institution of Dr. Czap has received research support from SVIN. The institution of Dr. Czap has received research support from AAN.
Elizabeth A. Coon, MD, FAAN	Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Hans H. Shuhaiber, MD	The institution of Dr. Shuhaiber has received research support from SPRINGWORKS . The institution of Dr. Shuhaiber has received research support from RECURSION . The institution of Dr. Shuhaiber has received research support from AstraZeneca. The institution of Dr. Shuhaiber has received research support from CTF. The institution of Dr. Shuhaiber has received research support from NFLECTION .
Prachi Mehndiratta, MD	Dr. Mehndiratta has nothing to disclose.
Matthew Scaramozza	Mr. Scaramozza has received personal compensation for serving as an employee of Biogen. Mr. Scaramozza has stock in Biogen. Mr. Scaramozza has received intellectual property interests from a discovery or technology relating to health care.
Shivani Ghoshal, MD	Dr. Ghoshal has nothing to disclose.
Matthew C. Kiernan, MBBS, PhD, FRACP	The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK).
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Eric A. Macklin, PhD	The institution of Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AI Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chase Therapeutics. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson Healthcare LLC. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Macklin has received research support from Biohaven. The institution of Dr. Macklin has received research support from Clene Nanomedicine. The institution of Dr. Macklin has received research support from Mitsubishi Tanabe Pharmaceuticals America. The institution of Dr. Macklin has received research support from Prilenia. The institution of Dr. Macklin has received research support from UCB Ra Pharma. The institution of Dr. Macklin has received research support from Revalesio. The institution of Dr. Macklin has received research support from Seelos. The institution of Dr. Macklin has received research support from Calico. The institution of Dr. Macklin has received research support from Denali. The institution of Dr. Macklin has received research support from NeuroDex. The institution of Dr. Macklin has received research support from Alector. The institution of Dr. Macklin has received research support from ITB-Med.
Sabrina Paganoni, MD, PhD	Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Sola. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Frequency Therapeutics. The institution of Dr. Paganoni has received research support from Amylyx. The institution of Dr. Paganoni has received research support from Revalesio. The institution of Dr. Paganoni has received research support from Alector. The institution of Dr. Paganoni has received research support from UCB. The institution of Dr. Paganoni has received research support from Biohaven. The institution of Dr. Paganoni has received research support from Clene. The institution of Dr. Paganoni has received research support from Prilenia. The institution of Dr. Paganoni has received research support from Seelos. The institution of Dr. Paganoni has received research support from Calico. The institution of Dr. Paganoni has received research support from Denali. The institution of Dr. Paganoni has received research support from Anelixis. The institution of Dr. Paganoni has received research support from Cytokinetics.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
David Vaillancourt	David Vaillancourt has received personal compensation for serving as an employee of Automated Imaging Diagnostics. David Vaillancourt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of David Vaillancourt has received research support from NIH. David Vaillancourt has received intellectual property interests from a discovery or technology relating to health care.
Christopher Giza, MD, FAAN	Dr. Giza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Network Speakers Bureau. Dr. Giza has stock in Highmark Interactive. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care. Dr. Giza has a non-compensated relationship as a Advisory Board with Major League Soccer that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Advisory Board with National Basketball Association that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Consultant with United States Soccer Federation that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Co-founder & Advisor with Symptomwise that is relevant to AAN interests or activities.
Michel Toledano, MD	Dr. Toledano has nothing to disclose.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
James D. Berry, MD MPH	Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to AAN interests or activities.
Anna Marisa Cervantes-Arslanian, MD, FAAN	Dr. Cervantes-Arslanian has nothing to disclose.
Sahar Zafar, MD	Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
Yaacov Anziska, MD	Dr. Anziska has nothing to disclose.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN	Dr. Sankaraneni has nothing to disclose.
Ariel Antezana, MD	Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Meeryo Choe, MD, FAAN	Dr. Choe has received personal compensation for serving as an employee of Harvard-Westlake School. Dr. Choe has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Cases. The institution of Dr. Choe has received research support from NIH. Dr. Choe has a non-compensated relationship as a Board of Directors with NABIS that is relevant to AAN interests or activities. Dr. Choe has a non-compensated relationship as a Consultant with USA Swimming Concussion Task Force that is relevant to AAN interests or activities.
Amelia K. Boehme, PhD	Dr. Boehme has nothing to disclose.
Guillaume Lamotte, MD, FAAN	Dr. Lamotte has nothing to disclose.
Shravan Sivakumar, MBBS	Dr. Sivakumar has nothing to disclose.
Umberto Manera, MD	Dr. Manera has nothing to disclose.
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Angela Wabulya, MB ChB	Dr. Wabulya has nothing to disclose.
Christopher P. Robinson, DO	Dr. Robinson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for law firms.
Nathaniel M. Robbins, MD	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.
Kaleb H. Yohay, MD	Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care.
Jacqueline A. Nicholas, MD	Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vielo Bio. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Nicholas has received research support from Novartis. The institution of Dr. Nicholas has received research support from Biogen. The institution of Dr. Nicholas has received research support from Genentech. The institution of Dr. Nicholas has received research support from PCORI. Dr. Nicholas has a non-compensated relationship as a Physician with National MS Society that is relevant to AAN interests or activities. Dr. Nicholas has a non-compensated relationship as a Physician with Siegal Rare Neuroimmune Association that is relevant to AAN interests or activities.
David J. Roh, MD	Dr. Roh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Portola Pharmaceuticals.
Carrie M. Hersh, DO, MSc, FAAN	Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Michelle Bell, MD	Dr. Bell has nothing to disclose.
Rawan Albadareen, MD	Dr. Albadareen has nothing to disclose.
Dariush Dowlatshahi, MD	Dr. Dowlatshahi has nothing to disclose.
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Carolyn Cronin, MD, PhD, FAAN	Dr. Cronin has nothing to disclose.
Muhammad M. Alvi, MD, FAAN	Dr. Alvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Christopher T. Whitlow, MD	Dr. Whitlow has nothing to disclose.
Devorah Segal, MD, PhD	Dr. Segal has nothing to disclose.
John Zurasky, MD	Dr. Zurasky has nothing to disclose.
Francois Bethoux, MD	No disclosure on file
Matthew Baker	No disclosure on file
Ricardo Alonso	Ricardo Alonso has nothing to disclose.
Kevin Bickart, MD, PhD	Dr. Bickart has nothing to disclose.
Mudassir Farooqui, MD	Dr. Farooqui has nothing to disclose.
Jesse Fischer	No disclosure on file
Eva Franzova, MD	Dr. Franzova has nothing to disclose.
Donald Grosset	Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Glasgow Memory Clinic. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. The institution of Donald Grosset has received research support from Parkinson's UK. Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Clinical Director Excellence Network with Parkinson's UK.
Patricio Millar Vernetti, MD	The institution of Dr. Millar Vernetti has received research support from NIH.
Marcelo Rocha, MD, PhD	The institution of Dr. Rocha has received research support from NIH.
Wanda Castro-Borrero, MD	Dr. Castro-Borrero has received personal compensation for serving as an employee of BIOGEN. Dr. Castro-Borrero has received stock or an ownership interest from BIOGEN.
Danielle Sandsmark, MD	The institution of Dr. Sandsmark has received research support from NINDS. The institution of Dr. Sandsmark has received research support from BrainBox Solutions Inc. The institution of Dr. Sandsmark has received research support from Department of Defense.
Daniel Torres, MD	Dr. Torres has received publishing royalties from a publication relating to health care.
Carolina B. Maciel, MD, MSCR, FAAN	Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
James J. Gugger, Jr., MD, PharmD	Dr. Gugger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. The institution of Dr. Gugger has received research support from American Epilepsy Society.
Riadh Gouider, MD, FAAN	Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Adalia H. Jun-O'Connell, MD, MBA, FAAN	Dr. Jun-O'Connell has received personal compensation in the range of $5,000-$9,999 for serving as a member with Women's Health Initiative.
Maria J. Bruzzone, MD, FAAN	Dr. Bruzzone has nothing to disclose.
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Matthieu Bereau	Matthieu Bereau has nothing to disclose.
Mehdi Ghasemi, MD	Dr. Ghasemi has nothing to disclose.
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Scott Grossman, MD	Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Sarah Lapointe, MD	Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lapointe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Salman Bhai, MD	Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KabaFusion. Dr. Bhai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bhai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. Bhai has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Bhai has received publishing royalties from a publication relating to health care.
Christina Wilson, MD, FAAN	Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH Stroke Net. The institution of an immediate family member of Dr. Wilson has received research support from NIH. An immediate family member of Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care.
Hans J. Moebius, MD, PhD, FAAN	Dr. Moebius has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Athira Pharma, Inc.. Dr. Moebius has stock in Athira Pharma, Inc..
Irfan Qureshi, MD	Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Luisa H. Klotz, MD	Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Derrick Robertson, MD	Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. The institution of Dr. Robertson has received research support from UCB Biosciences. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Amanda L. Piquet, MD, FAAN	The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
James N. Brenton, MD, FAAN	Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Michelle Kaku, MD	Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.
Rohini D. Samudralwar, MD	Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Aaron M. Carlson, MD	Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Lidia Maria V. Moura, MD, PhD, MPH, FAAN	Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation .
Alicia Zha, MD	The institution of Dr. Zha has received research support from ��ɫ��. The institution of Dr. Zha has received research support from American Board of Psychiatry and Neurology.
Clio A. Rubinos, MD, MSCR	Dr. Rubinos has nothing to disclose.
Antonio Canosa	Antonio Canosa has nothing to disclose.
Shivika Chandra, MD, FAAN	The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in ��ɫ�� Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Jenny Meyer, MD	The institution of Dr. Meyer has received research support from Grifols. The institution of Dr. Meyer has received research support from Medicinova.
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
James Im, MD	Dr. Im has nothing to disclose.
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Brandi L. Vollmer, MPH	Ms. Vollmer has nothing to disclose.
Hiroaki Sekiya, MD, PhD	Dr. Sekiya has nothing to disclose.
Silvia Presas	Silvia Presas has nothing to disclose.
Amina Nasri, MD	Dr. Nasri has nothing to disclose.
Ajay Malhotra	Ajay Malhotra has nothing to disclose.
Hong Yu, MD	No disclosure on file
Abbas Kharal, MD	Dr. Kharal has nothing to disclose.
Lauren Jackson, MD	Dr. Jackson has nothing to disclose.
Perrin A. Pleninger, MD, FAAN	Dr. Pleninger has nothing to disclose.
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Patrick M. Kochanek, MD, MCCM	Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Washington. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johns Hopkins Health System. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for de Boisblanc Law Firm. The institution of Patrick M. Kochanek, MD, MCCM has received research support from Chuck Noll Foundation. The institution of Patrick M. Kochanek, MD, MCCM has received research support from NIH. Patrick M. Kochanek, MD, MCCM has received publishing royalties from a publication relating to health care.
Jessica Stulc, MD	Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono . Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD serono . Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Stulc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi . The institution of Dr. Stulc has received research support from EMD serono . The institution of Dr. Stulc has received research support from Novartis . The institution of Dr. Stulc has received research support from Sanofi . The institution of Dr. Stulc has received research support from Genentech. The institution of Dr. Stulc has received research support from Biogen.
Ritvij Bowry, MD	Dr. Bowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca.
Katherine E. Leaver, MD	Dr. Leaver has nothing to disclose.
Philip W. Tipton, MD	Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
K. H. Vincent Lau, MD	Dr. Lau has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Lau has or had stock in Alnylam Pharmaceuticals.
Jesse Thon, MD	An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Elina Zakin, MD, FAAN	The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Madeline Garza, MD	Dr. Garza has nothing to disclose.
Laura K. Stein, MD, MPH	The institution of Dr. Stein has received research support from American Heart Association.
Aliza B. Ben-Zacharia, PhD, DNP, ANP, FAAN	Ms. Ben-Zacharia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences. Ms. Ben-Zacharia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Theraputics. The institution of Ms. Ben-Zacharia has received research support from Biogen. The institution of Ms. Ben-Zacharia has received research support from Greenwich Biosciences.
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Eric Engebretson	Mr. Engebretson has nothing to disclose.
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Carolyn Tsai, MD	Dr. Tsai has nothing to disclose.
Bernd C. Kieseier, MD	Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Fatemah Alshawaf, MD	Dr. Alshawaf has nothing to disclose.
Jessica Kiarashi, MD	Dr. Kiarashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for COVE.
Allison Snyder, MD	Dr. Snyder has nothing to disclose.
Shima Bozorgui, MD	Dr. Bozorgui has nothing to disclose.
Clifton Lewis, DO	Dr. Lewis has nothing to disclose.
Joseph M. Palumbo, MD	Dr. Palumbo has received personal compensation for serving as an employee of BioVie. An immediate family member of Dr. Palumbo has received personal compensation for serving as an employee of Merck Research Laboratories. Dr. Palumbo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stalicla SA. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Psychae Therapeutics Pty Ltd. Dr. Palumbo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Phocus Pharmaceuticals Inc.. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BioVie. Dr. Palumbo has or had stock in BioVie. An immediate family member of Dr. Palumbo has or had stock in Merck Research Laboratories. The institution of Dr. Palumbo has received research support from United States Department of Defense. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care.
Katrina Paumier, PhD	Dr. Paumier has nothing to disclose.
Azizi Seixas	No disclosure on file
Stefan Sillau	Stefan Sillau has nothing to disclose.
Kathryn Grimes, MD	Dr. Grimes has nothing to disclose.
Robert Hamilton, PhD	Dr. Hamilton has received personal compensation for serving as an employee of NovaSignal Corp . Dr. Hamilton has received stock or an ownership interest from NovaSignal Corp. Dr. Hamilton has received intellectual property interests from a discovery or technology relating to health care.
Catherine D. Chong, PhD, FAAN	Dr. Chong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HCOP.
Eufrosina I. Young, MD	The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Johannes Pulst-Korenberg, MD	Dr. Pulst-Korenberg has nothing to disclose.
Nada A. Hindiyeh, MD	Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck .
Paula E. Voinescu, MD	The institution of Dr. Voinescu has received research support from Epilepsy Foundation of New England. The institution of Dr. Voinescu has received research support from BWH - Connors Center. The institution of an immediate family member of Dr. Voinescu has received research support from American Epilepsy Society. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Phillipines League Against Epilepsy. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a PhD Opponent with University of Bergen, Norway. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
Anoopum Gupta, MD, PhD	Dr. Gupta has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biogen. The institution of Dr. Gupta has received research support from Biogen.
Shannon Y. Chiu, MD, MSc	Dr. Chiu has received research support from NIH.
Sami Alkasab, MD	Dr. Alkasab has nothing to disclose.
Andrea L. Schneider, MD, PhD	Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.
Katerina Mensikova	Katerina Mensikova has nothing to disclose.
Kaitlyn Lillemoe, MD	Dr. Lillemoe has nothing to disclose.
James Doherty, PhD	Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics.
Maha Daimee, MD	Dr. Khan has nothing to disclose.
Negin Badihian, MD	Dr. Badihian has nothing to disclose.
Maria G. Martucci, MD	Dr. Martucci has nothing to disclose.
Gina Dumkrieger, PhD	Gina Dumkrieger has received personal compensation for serving as an employee of Mayo Clinic. The institution of Gina Dumkrieger has received research support from NIH. The institution of Gina Dumkrieger has received research support from DOD. The institution of Gina Dumkrieger has received research support from AMGEN.
Gabriel Rodriguez	Gabriel Rodriguez has nothing to disclose.
Roger Cady, MD	Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Shannon C. Shipley, MD	Dr. Shipley has nothing to disclose.
Stephanie Allien, PA	Mrs. Allien has nothing to disclose.
Steven Kymes	Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Spyros Papapetropoulos	No disclosure on file
Federico J. Rodriguez-Porcel, MD, FAAN	Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioVie. Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG. Dr. Rodriguez-Porcel has received research support from NIH. Dr. Rodriguez-Porcel has received publishing royalties from a publication relating to health care.
Stephanie L. Bissonnette, DO	The institution of Dr. Bissonnette has received research support from SAGE Therapeutics. The institution of Dr. Bissonnette has received research support from Huntington's Disease Society of America. The institution of Dr. Bissonnette has received research support from CHDI Foundation.
Corey M. Thibeault, PhD	Dr. Thibeault has received personal compensation for serving as an employee of NovaSignal Corp.. Dr. Thibeault has received stock or an ownership interest from NovaSignal Inc..
Jennifer L. Orthmann Murphy, MD, PhD	Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for Vigil Neuroscience. Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoGlia. The institution of Dr. Orthmann Murphy has received research support from Vigil Neurosciences. The institution of Dr. Orthmann Murphy has received research support from National MS Society. The institution of Dr. Orthmann Murphy has received research support from Fishman Family Foundation. The institution of Dr. Orthmann Murphy has received research support from Global Leukodystrophy Initiative Clinical Trial Network. The institution of Dr. Orthmann Murphy has received research support from NINDS. The institution of Dr. Orthmann Murphy has received research support from Montague Investigator Award. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Developing CME content on Neurogenetics with American Neurological Association. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Faculty, Honoraria with CMSC.
Fernanda Jacinto Pereira Teixeira, MD	Dr. Jacinto Pereira Teixeira has nothing to disclose.
Ehad Afreen, MD	Dr. Afreen has nothing to disclose.
Maria V. Diaz Rojas, MD	Dr. Diaz Rojas has nothing to disclose.
Anthony M. Bradshaw, MD	Dr. Bradshaw has nothing to disclose.
Jian Xu, MD, PhD	Dr. Xu has nothing to disclose.
Marion Oliver, MD	Dr. Oliver has nothing to disclose.
Micah Etter, MD	Dr. Etter has nothing to disclose.
Fabiola De Marchi	Fabiola De Marchi has nothing to disclose.
Kevin Winthrop	Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson & Johnson .
Minyoul Baik, Jr., MD	Dr. Baik has nothing to disclose.
Anas M. Alrohimi, MD	Dr. Alrohimi has nothing to disclose.
Darshan Pandya, MD	Dr. Pandya has nothing to disclose.
Jenna Ford, MD	Dr. Ford has nothing to disclose.
Daniel M. Oh, MD	Dr. Oh has nothing to disclose.
Joseph T Nguyen	Joseph T Nguyen has nothing to disclose.
Kush Sharma, MBBS	Dr. Sharma has nothing to disclose.
Enrique Urrea-Mendoza, MD	Dr. Urrea-Mendoza has nothing to disclose.
Dennis W. Simon, MD	Dr. Simon has nothing to disclose.
Triza Brion	No disclosure on file
Brandon Giglio, MD	Dr. Giglio has nothing to disclose.
Visar Berisha	Visar Berisha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Visar Berisha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer Ingelheim. Visar Berisha has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Aural Analytics. Visar Berisha has received stock or an ownership interest from Aural Analytics. The institution of Visar Berisha has received research support from Boheringer Ingelheim. Visar Berisha has received intellectual property interests from a discovery or technology relating to health care.
Santiago Ortega Gutierrez, MD	Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH. The institution of Dr. Ortega Gutierrez has received research support from PCORI.
Charles R. Joseph, MD	Dr. Joseph has nothing to disclose.
Marcella A. Wozniak, MD, PhD	Dr. Wozniak has nothing to disclose.
A. G. C. Bergqvist, MD	Dr. Bergqvist has nothing to disclose.
Carole Ho, MD	No disclosure on file
Shavonne Massey, MD	Dr. Massey has a non-compensated relationship as a consultant with Sun Pharmaceutical Ltd that is relevant to AAN interests or activities.
Venka Veerappan, MD	Dr. Veerappan has nothing to disclose.
Rana Moosavi, MD	Dr. Moosavi has nothing to disclose.
James B. Lewin, PharmD	Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Mihir Kakara, MD	Dr. Kakara has nothing to disclose.
Sonal Sharma, MD	Dr. Sharma has nothing to disclose.
Sakinah Sabadia, MD	Dr. Sabadia has nothing to disclose.
Shashvat Desai, MD	Dr. Desai has nothing to disclose.
Hernan Nicolas Lemus Esquivel, MD	Dr. Lemus Esquivel has nothing to disclose.
Murat Sari, MD	The institution of Dr. Sari has received research support from NIH/NINDS.
Rosario Vasta, MD	Dr. Vasta has nothing to disclose.
Mohamad Abdalkader	Mohamad Abdalkader has nothing to disclose.
Irina Agarkova	No disclosure on file
Nada Ahmed, MD	Dr. Ahmed has nothing to disclose.
Andrew Heim	Andrew Heim has nothing to disclose.
Huanwen Chen, MD	Dr. Chen has nothing to disclose.
David Dunigan	No disclosure on file
Victoria Wirtz	Victoria Wirtz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Victoria Wirtz has stock in Biohaven.
Guillaume Robert	No disclosure on file
Tom Petro	No disclosure on file
James Van Etten	No disclosure on file
Cynthia Wong	Cynthia Wong has received personal compensation for serving as an employee of Alterity Therapeutics. An immediate family member of Cynthia Wong has received personal compensation for serving as an employee of RefleXion Medical. Cynthia Wong has stock in Teva. An immediate family member of Cynthia Wong has stock in 10x Genomics.
Sherief Ghozy	Mr. Ghozy has nothing to disclose.
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
John J. Leddy, MD, FACSM, FACP	Dr. Leddy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zeiss. Dr. Leddy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeckCare. Dr. Leddy has stock in 360 Concussion Care. The institution of Dr. Leddy has received research support from DoD.
James Hiana, MD	Dr. Hiana has nothing to disclose.
Marissa Anto, MD	Dr. Anto has nothing to disclose.
Manon Auffret, PhD, PharmD, DAAN	Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aguettant. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aguettant. The institution of Dr. Auffret has received research support from Oxylis Medical. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care.
Mohammad N. Haider	Mr. Haider has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Blink TBI. Mr. Haider has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Blink CNS. Mr. Haider has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oculogica Inc. Mr. Haider has stock in Headquarters Health. The institution of Mr. Haider has received research support from NIH. Mr. Haider has received research support from Headquarters Health. The institution of Mr. Haider has received research support from CDMRP/PRMRP.
Greer Waldrop, MD	Dr. Waldrop has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Waldrop has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Jennifer Axelband, DO	Dr. Axelband has nothing to disclose.
Nuriel Moghavem, MD	Dr. Moghavem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Multiple Sclerosis Association of America. Dr. Moghavem has a non-compensated relationship as a Committee Member with National Multiple Sclerosis Society that is relevant to AAN interests or activities. Dr. Moghavem has a non-compensated relationship as a Board Member with Los Angeles County Medical Association that is relevant to AAN interests or activities.
Elizabeth Matthews, MD	Dr. Matthews has nothing to disclose.
Jeffery R. Tenney, MD, PhD	Dr. Tenney has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wilson Smith Cochran Dickerson. The institution of Dr. Tenney has received research support from NIH.
Mary T. Silvia, MD	Dr. Silvia has nothing to disclose.
Andy Cheadle, PhD	Dr. Cheadle has received personal compensation for serving as an employee of Novartis. Dr. Cheadle has stock in Novartis. Dr. Cheadle has stock in Teva.
Sungyang Jo, MD	Dr. Jo has nothing to disclose.
Rachel Kenney	Rachel Kenney has received personal compensation for serving as an employee of Optum. Rachel Kenney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minton ��ɫ�� LLC.
Blake Beehler, MD	Dr. Beehler has nothing to disclose.
Richa Thakkar, DO	Dr. Thakkar has nothing to disclose.
Benjamin Stuart, MD	Dr. Stuart has nothing to disclose.
Emma L. Wetmore, MD	Dr. Wetmore has nothing to disclose.
Kaho Onomichi	Kaho Onomichi has nothing to disclose.
Theodore Stem	No disclosure on file
Rakhee Lalla, DO	Dr. Lalla has received personal compensation in the range of $0-$499 for serving as a Consultant for Women's health initiative .
Rahul Chandra, MD	Dr. Chandra has nothing to disclose.
Houman Khosravani, MD, PhD	Dr. Khosravani has nothing to disclose.
Nadia Khalil, MD	Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a Resident and Fellow Council Member with American Association of Neuromuscular & Electrodiagnostic Medicine. Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a MS Mentorship Forum Participant with Foundation of the Consortium of Multiple Sclerosis Centers.
Maurizio Grassano, MD	Dr. Grassano has received research support from American Brain Foundation, ALS Association and ��ɫ��.
Ashley Nelson, DO	Dr. Nelson has nothing to disclose.
Aaron Koenig	Aaron Koenig has received personal compensation for serving as an employee of Sage Therapeutics.
Pranav Gandhi	Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Ece Bayram, MD, PhD	The institution of Dr. Bayram has received research support from National Institute on Aging (K99AG073453). The institution of Dr. Bayram has received research support from Lewy Body Dementia Association. The institution of Dr. Bayram has received research support from National Institute of Neurological Disorders and Stroke.
Enmanuel Perez, MD, PhD	Dr. Perez has nothing to disclose.
Sara Hooshmand, MD	Dr. Hooshmand has nothing to disclose.
Karan Hingorani, MD, PhD	Dr. Hingorani has nothing to disclose.
Lauren A. Neal	Miss Neal has nothing to disclose.
Ashley Santilli, MD	Dr. Santilli has nothing to disclose.
Krithika Umesh Peshwe, MD	Dr. Peshwe has nothing to disclose.
Christopher A. Sheridan, CSCS	Mr. Sheridan has nothing to disclose.
Linus D. Sun, MD, PhD	Dr. Sun has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Sun has stock in Denali Therapeutics.
Olaf Hoffmann, MD	Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hoffmann has received research support from Biogen. The institution of Dr. Hoffmann has received research support from Novartis. The institution of Dr. Hoffmann has received research support from Sanofi.
Andrea J. Bartels, NP	Ms. Bartels has nothing to disclose.
Brian Pfister	Dr. Pfister has received personal compensation for serving as an employee of Praxis Precisions Medicines. Dr. Pfister has stock in Praxis Precision Medicines.
Roberta Diaz Brinton, PhD	Roberta Diaz Brinton, PhD has nothing to disclose.
Sai L. Shankar, PhD, FAAN	Dr. Shankar has received personal compensation for serving as an employee of Biogen. Dr. Shankar has stock in Biogen.
Burkhard Blank	Burkhard Blank has received personal compensation for serving as an employee of Acorda Therapeutics. Burkhard Blank has received stock or an ownership interest from Acorda Therapeutics, Inc.
Mustafa Al-Chalabi, DO	Dr. Al-Chalabi has nothing to disclose.
Muhammad Bilal Tariq, MBBS	Dr. Tariq has nothing to disclose.
Eric Stulberg, MD	Dr. Stulberg has nothing to disclose.
Katherine Ross	Katherine Ross has nothing to disclose.
Maysen Mesaros	Maysen Mesaros has nothing to disclose.
Cesar Alves	No disclosure on file
Roseanne Sullivan	Roseanne Sullivan has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Roseanne Sullivan has stock in Novartis Pharmaceuticals.
Samiksha Srivastava, MD	Dr. Srivastava has nothing to disclose.
Ayan Das Gupta	Ayan Das Gupta has received personal compensation for serving as an employee of Novartis Health Care Pvt. Ltd.
William Huynh, MD	Dr. Huynh has nothing to disclose.
Shunsuke Koga, MD, PhD	Dr. Koga has nothing to disclose.
Jonathan R. Brent, MD, PhD	Dr. Brent has received research support from The ��ɫ��.
Ghazala Saleem	No disclosure on file
Barry Willer	No disclosure on file
Mehul Mehra	Mr. Mehra has received research support from Medical College of Georgia. Mr. Mehra has received personal compensation in the range of $500-$4,999 for serving as a Graduate SGA Humanitarian with Augusta University.
Pierce Brody	Mr. Brody has nothing to disclose.
Angela M. Velazquez, MD	Dr. Velazquez has nothing to disclose.
Rajeshwari Mahalingam, MD	Dr. Mahalingam has nothing to disclose.
Brian M. Sauer, MD	The institution of Dr. Sauer has received research support from Annexon, Inc.. The institution of Dr. Sauer has received research support from Patient Centered Outcomes Research Center via Mayo Clinic. The institution of Dr. Sauer has received research support from Argenx. The institution of Dr. Sauer has received research support from NINDS & Amgen, Inc.. The institution of Dr. Sauer has received research support from Bristol Myers Squibb; Janssen Pharmaceutical Companies of Johnson & Johnson. The institution of Dr. Sauer has received research support from Genetech Hoffmann-La Roche. The institution of Dr. Sauer has received research support from UCB Biopharma SRL. Dr. Sauer has a non-compensated relationship as a Advisory Board Member, Neuroscience Advisor with Donor Alliance, Inc. that is relevant to AAN interests or activities.
Virginia DeLasHeras	Virginia DeLasHeras has received personal compensation for serving as an employee of NOVARTIS.
Mekka R. Garcia, MD	Dr. Garcia has nothing to disclose.
Maria Ait Tihyaty	Dr. Ait Tihyaty has received personal compensation for serving as an employee of Dianthus Therapeutics.
Ma Su Su Aung, MD	Dr. Aung has nothing to disclose.
Juan J. Mendez Gallardo, MD	Dr. Mendez Gallardo has nothing to disclose.
Trilok Stead	Trilok Stead has nothing to disclose.
Gerson D. Hernandez Rivera, MD, MPH	Dr. Hernandez Rivera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuTherapeutics. The institution of Dr. Hernandez Rivera has received research support from National Institute on Aging. The institution of Dr. Hernandez Rivera has received research support from National Institute on Aging.
Leo Coutinho, MD	Dr. Coutinho has nothing to disclose.
Ankita Tripathi, MD	Dr. Tripathi has nothing to disclose.
James Simples, Jr., PhD	Dr. Simples has stock in Janssen.
Susan Durham	Susan Durham has received personal compensation for serving as an employee of Biohaven. Susan Durham has stock in Biohaven.
Marie-Hélène Quesnel-Olivo, MD	Dr. Quesnel-Olivo has nothing to disclose.
Adam T. Mierzwa, MD	Dr. Mierzwa has nothing to disclose.
Monica Kim, DO	Miss Kim has nothing to disclose.
Yasaman Pirahanchi, MD	Dr. Pirahanchi has nothing to disclose.
Lena Liu, MD	Dr. Liu has nothing to disclose.
Khaled Gharaibeh, MD	Dr. Gharaibeh has nothing to disclose.
Bhavya Narapureddy, MBBS	Dr. Narapureddy has nothing to disclose.
Muhammad Aemaz Ur Rehman, MD	Dr. Aemaz Ur Rehman has nothing to disclose.
Vanessa Dwairi, MD	Dr. Dwairi has nothing to disclose.
Ibrahim Turkoz	Ibrahim Turkoz has received personal compensation for serving as an employee of Johnson and Johnson. Ibrahim Turkoz has stock in Johnson and Johnson.
Megan Dini, MA	Mrs. Dini has received personal compensation for serving as an employee of Parkinson's Foundation .
Ronald Zielman	No disclosure on file
Juan A. Vivanco-Suarez, MD	Mr. Vivanco-Suarez has nothing to disclose.
Cecilia Quarracino Benchetrit, MD	Mrs. Quarracino Benchetrit has nothing to disclose.
Nora R. Jandhyala, MD	Ms. Jandhyala has nothing to disclose.
Michelle H. Tosin, PhD, RN	Dr. Tosin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuraLight . The institution of Dr. Tosin has received research support from International Parkinson and Movement Disorders Society. Dr. Tosin has received personal compensation in the range of $500-$4,999 for serving as a Consultant with International Parkinson and Movement Disorders Society.
Xixi Hu	Xixi Hu has received personal compensation for serving as an employee of Novartis. Xixi Hu has stock in Novartis.
Ivan Bozin	Dr. Bozin has received personal compensation for serving as an employee of Biogen. Dr. Bozin has received personal compensation for serving as an employee of Arvelle Therapeutics. Dr. Bozin has stock in Biogen.
Milagros Galecio-Castillo, MD	Dr. Galecio-Castillo has nothing to disclose.
Corey Puryear, PhD	Dr. Puryear has received personal compensation for serving as an employee of Praxis Precision Medicine. Dr. Puryear has stock in Praxis Precision Medicines.
Tahereh Kamali, PhD	Dr. Kamali has nothing to disclose.
Margie Campbell	Margie Campbell has nothing to disclose.
Jessie Iregui	Miss Iregui has nothing to disclose.
Michele Potashman, PhD	Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Claudia Lopez	Mrs. Lopez has nothing to disclose.
Brooke Valdez	Brooke Valdez has nothing to disclose.
Amy Wynn, NP	Ms. Wynn has nothing to disclose.
Krutika Jariwala-Parikh, PhD	Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie.
Marina Ziehn, PhD	No disclosure on file
Gina Mavrikis Cox, PhD	Dr. Mavrikis Cox has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Dr. Mavrikis Cox has stock in Novartis Pharmaceuticals.
Robert J. Sharkus III, DO	Dr. Sharkus has nothing to disclose.
Nick Mannix, MD	Dr. Mannix has nothing to disclose.
Aaron E. Rodriguez-Calienes	Dr. Rodriguez-Calienes has nothing to disclose.
Bryce Allen Bagley	Mr. Bagley has received personal compensation for serving as an employee of Stanford University.
Anne Marie Morse	No disclosure on file
Jasmine S. Coles	Miss Coles has nothing to disclose.
Julien Rousseau, MD, CM	Dr. Rousseau has nothing to disclose.
Sydney Chatfield, MD	Dr. Chatfield has nothing to disclose.
Valerie Braddick, MD	Ms. Braddick has nothing to disclose.
Elena Penhos, MD	Ms. Penhos has nothing to disclose.
Bakhtawar Ahmad, MBBS	Dr. Ahmad has nothing to disclose.
Michelle Dompenciel, MD	Dr. Dompenciel has nothing to disclose.
Michael S. Oldham, MD, MPH	Dr. Oldham has received personal compensation for serving as an employee of Praxis Precision Medicines.
Viktoriya Katsnelson, MD	Dr. Katsnelson has nothing to disclose.
Shanna Swartwood, MD	Dr. Swartwood has nothing to disclose.
Luke Heyliger, MD	Dr. Heyliger has nothing to disclose.
Cheng Chin Wang, DO	Dr. Wang has nothing to disclose.
Fatemeh Sobhani Sweeney, MD	Dr. Sobhani Sweeney has nothing to disclose.
Kholoud Altarazi, MD	Dr. Altarazi has nothing to disclose.
Mordechai Z. Smith, MD	Dr. Smith has nothing to disclose.
Jeremy Ader, MD	Dr. Ader has nothing to disclose.
Morgan McGrath	Mrs. McGrath has received research support from NIH. Mrs. McGrath has received intellectual property interests from a discovery or technology relating to health care.
Michael P. Skolka, MD	Dr. Skolka has nothing to disclose.
Audrey Wadood, MD	Dr. Wadood has nothing to disclose.
Jose P. Falero Pomales, MD	Dr. Falero Pomales has nothing to disclose.
Samuel Durojaye, MD	Dr. Durojaye has nothing to disclose.
Nicholas K. Sammond, DO	Dr. Sammond has nothing to disclose.
Jose Marino Granados, MD	Dr. Marino Granados has nothing to disclose.
Christopher C. Anderson, MD	Dr. Anderson has received publishing royalties from a publication relating to health care.
Bridget Ollesch, MD	Dr. Ollesch has nothing to disclose.
Jacob B. Perlman, MD	Dr. Perlman has nothing to disclose.
Reece Hass, DO	Dr. Hass has nothing to disclose.
Jorge A. Matta, MD	Dr. Matta has nothing to disclose.
Delini Sivakumar, MD	Dr. Sivakumar has nothing to disclose.
Alessandra Filpo, MD	Dr. Filpo has nothing to disclose.
Patrick O'Connor, MD	Dr. O'Connor has nothing to disclose.
Anita Rau, MD	Dr. Rau has nothing to disclose.
Shruthi Harish, MBBS	Dr. Harish has nothing to disclose.
Matthew S. Davitz, MD	Dr. Davitz has nothing to disclose.
Jessica E. Decker, DO	Dr. Decker has nothing to disclose.
Ifeyinwa Asonye, MD	Dr. Nwankwo has nothing to disclose.
María Paula Aguilera Peña, MD	María Paula Aguilera Peña, MD has nothing to disclose.
Kaneez Zahra, MD, MBBS	Dr. Zahra has nothing to disclose.
Dafne L. Bayer, MD	Dr. Bayer has nothing to disclose.
Jose Miguel Valdes, MD	Dr. Valdes has nothing to disclose.
Leonardino Digma, MD	Mr. Digma has nothing to disclose.
Olga Manouvakhova, MD	Dr. Manouvakhova has nothing to disclose.
Emanuel Cassou, MD	Dr. Cassou has nothing to disclose.
Kristin Reilly	Kristin Reilly has received personal compensation for serving as an employee of Janssen Scientific Affairs, LLC. Kristin Reilly has stock in Johnson & Johnson.
Holly Sim, MD	Dr. Sim has nothing to disclose.
Yohannes S. Mulatu, MD	Dr. Mulatu has nothing to disclose.
Jonathan W. Handshoe, MD	Dr. Handshoe has nothing to disclose.
Briana Wasserstrom, DO	Dr. Wasserstrom has nothing to disclose.
Ramsha Farrukh, MD	Dr. Farrukh has nothing to disclose.
Nameer Aladamat, MBBS	Dr. Aladamat has nothing to disclose.
Poojith Nuthalapati, MD	Mr. Nuthalapati has nothing to disclose.
Mohammad Taimur Shujaat	No disclosure on file
Jarrod Rulney	Mr. Rulney has nothing to disclose.
Beatriz Cassarotti, MD	Miss Cassarotti has nothing to disclose.
Madison McGann	Ms. McGann has nothing to disclose.
Lorna Marisalva Galleguillos Goiry	Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Lorna Marisalva Galleguillos Goiry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi.
Mazhar Khalid, MD, MBBS	Dr. Khalid has nothing to disclose.
Kriti Bhayana, MD	Dr. Bhayana has nothing to disclose.
Shan Ali, MD	Dr. Ali has nothing to disclose.
Stephanie Q. Liang, MD	Dr. Liang has nothing to disclose.
Rosemary P. Gomes, MD	Dr. Gomes has nothing to disclose.
Hope Okpokam, MD	Dr. Okpokam has nothing to disclose.
Melinda C. Arthur, DO	Dr. Arthur has nothing to disclose.
Samuel Lee, DO	Dr. Lee has nothing to disclose.
Marija Zivcevska	Ms. Zivcevska has nothing to disclose.
Alexis George	Ms. George has nothing to disclose.
Bruno Cenni, PhD	No disclosure on file
Christina Szperka	No disclosure on file
Nicholas Mallett, MD	Dr. Mallett has nothing to disclose.
Malak AlMojel, MD	Dr. AlMojel has nothing to disclose.
Rajasimhan Rajagovindan, PhD	Dr. Rajagovindan has received personal compensation for serving as an employee of Biogen. Dr. Rajagovindan has received personal compensation for serving as an employee of Vigil. Dr. Rajagovindan has stock in Biogen. Dr. Rajagovindan has stock in Vigil .
Elke Schipani, MD	Dr. Schipani has nothing to disclose.
Saisree Ravi, MD	Dr. Ravi has nothing to disclose.
Brent A. Willman-Yoswa	Mr. Willman-Yoswa has received personal compensation for serving as an employee of Denali Therapeutics.
Bakhtawar Ahmad, MBBS	No disclosure on file
Jubin Kang	Ms. Kang has nothing to disclose.
Mohammad Mahmud, MBBS	Mr. Mahmud has nothing to disclose.
Jamir Pitton Rissardo, MD	Dr. Pitton Rissardo has nothing to disclose.
Ryoichi Inoue, MD	Dr. Inoue has nothing to disclose.
Kanika Sharma	Ms. Sharma has nothing to disclose.
Ahmad M. Almelegy, MD	Dr. Almelegy has nothing to disclose.
Muhammad Saim	Mr. Saim has nothing to disclose.
Stephane Regnier, PhD	Mr. Regnier has received personal compensation for serving as an employee of Lundbeck. Mr. Regnier has received personal compensation for serving as an employee of Novartis. Mr. Regnier has stock in Novartis.
Susanne Awad	Susanne Awad has received personal compensation for serving as an employee of Lundbeck.
Pierre Trudel	Mr. Trudel has nothing to disclose.
Andree-Anne Berthiaume	No disclosure on file
Danyaal Buttar	Mr. Buttar has nothing to disclose.
Ahmed Esmael	No disclosure on file
Xin Ying Lee	No disclosure on file
Artur Menegaz de Almeida, MS	Mr. Menegaz de Almeida has nothing to disclose.
Robert H. Cascella	Mr. Cascella has nothing to disclose.
Cordula Weiss, PhD	Dr. Weiss has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Kaya G. Jordan, CRC	Ms. Jordan has nothing to disclose.
Elisabeth Rindner	Ms. Rindner has nothing to disclose.
Andres Felipe Cardenas Cruz, Jr., MD	Dr. Cardenas Cruz has nothing to disclose.
Maycky Tang, DO	Dr. Tang has nothing to disclose.
Aarti R. Katara	Ms. Katara has nothing to disclose.
Ryan Kaya, PT	Mr. Kaya has nothing to disclose.
Marcell P. Szabo	Mr. Szabo has nothing to disclose.
Ishah Yusaf, Other	Ms. Yusaf has nothing to disclose.
Sherif Reda	Sherif Reda has received personal compensation for serving as an employee of Athira Pharma, Inc.. Sherif Reda has stock in Athira Pharma, Inc..
Jewel Johnston	Dr. Johnston has received personal compensation for serving as an employee of Athira Pharma, Inc. Dr. Johnston has stock in Athira Pharma, Inc. An immediate family member of Dr. Johnston has stock in Athira Pharma, Inc. Dr. Johnston has received intellectual property interests from a discovery or technology relating to health care.
Kevin Church, PhD	Dr. Church has received personal compensation for serving as an employee of Athira Pharma. Dr. Church has stock in Athira Pharma. Dr. Church has received intellectual property interests from a discovery or technology relating to health care.
Maurish Fatima	Miss Fatima has nothing to disclose.
Aila Rahman	Miss Rahman has nothing to disclose.
Khushalee Oza	Miss Oza has nothing to disclose.
Ieshia Deal	No disclosure on file
Joanna Hong	Miss Hong has nothing to disclose.
Rizk Alghorazi	Mr. Alghorazi has nothing to disclose.
Kei Sugiura, MD	Dr. Sugiura has nothing to disclose.
Jessica Glenn, NP	Mrs. Glenn has nothing to disclose.
Abigail S. Betner, MLS	Mrs. Betner has nothing to disclose.
Jaroslaw Dulski, MD, PhD	Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VM Media Ltd.. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Radoslaw Lipinski 90 Consulting. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Dulski has received research support from Polish Neurological Society. Dr. Dulski has received research support from Polish National Agency for Academic Exchange. Dr. Dulski has received intellectual property interests from a discovery or technology relating to health care.
Kayla Kleist	No disclosure on file
Syed Mehdi Husaini, MD	Mr. Husaini has nothing to disclose.
Carlton Anderson, PhD	Mr. Anderson has nothing to disclose.
Enrico Matteoni	No disclosure on file
Ian S. Dorman	Mr. Dorman has nothing to disclose.
Carolina García Alfonso	No disclosure on file
Eslam M. Rabea	Mr. Rabea has nothing to disclose.
Sriramkumar Sridharan	Mr. Sridharan has nothing to disclose.
Teresa Wu	Teresa Wu has nothing to disclose.
Lingchao Mao	Ms. Mao has nothing to disclose.
Carlos Alberto Campello	No disclosure on file
Piers Klein	Mr. Klein has nothing to disclose.
Mahmoud A. Khalifa	Mr. Khalifa has nothing to disclose.
Pedro D. Amatto	Mr. Amatto has nothing to disclose.
Conor Reid	Mr. Reid has nothing to disclose.
Alan Blau, PhD	Dr. Blau has received personal compensation for serving as an employee of Corium, LLC.
Cassandra Forrest	Cassandra Forrest has nothing to disclose.
Jing Li	Jing Li has nothing to disclose.
Amy Goldstein	Amy Goldstein has received personal compensation in the range of $500-$4,999 for serving as a speaker with UMDF.
Trevor Nelson	Mr. Nelson has nothing to disclose.
Emily Feeney	Ms. Feeney has nothing to disclose.
Shima Shahjouei, MD, MPH	Dr. Shahjouei has nothing to disclose.
Bradley W. Clark	Mr. Clark has nothing to disclose.
Gabriel Marinheiro Dos Santos-Bezerra	Gabriel Marinheiro Dos Santos-Bezerra has nothing to disclose.
Mohammad Rehman	No disclosure on file
Lindsay Pothier	No disclosure on file
Judith Dunmore	No disclosure on file
Anna Newman	Ms. Newman has nothing to disclose.
Kris Kahlig, PhD	Dr. Kahlig has received personal compensation for serving as an employee of Praxis Precisoin Medicines. Dr. Kahlig has stock in Praxis Precision Medicines.
Henry Jacotin	Henry Jacotin has received personal compensation for serving as an employee of Praxis Precision Medicines. Henry Jacotin has stock in Praxis Precision Medicines. Henry Jacotin has stock in Clover Health. Henry Jacotin has stock in Certara. Henry Jacotin has stock in Takeda. Henry Jacotin has received personal compensation in the range of $500,000-$999,999 for serving as a VP Clinical Development and Pharmacovigilance with Praxis Precision Medicines.
Alani Jack	Ms. Jack has nothing to disclose.
Jonathon Lebovitz	Jonathon Lebovitz has stock in Vesalio NeuroVascular.
Om Sakhalkar	Mr. Sakhalkar has nothing to disclose.
Dongliang Wang	Dongliang Wang has nothing to disclose.
Sherry Fung	Ms. Fung has nothing to disclose.
Samarah Ahmed	Ms. Ahmed has nothing to disclose.
Zoe Parrales	No disclosure on file
Marta Fernandes	Marta Fernandes has nothing to disclose.
Kelsey Owen	No disclosure on file
Jonathan Stokes	Jonathan Stokes has nothing to disclose.
Simran Mehrotra	Miss Mehrotra has nothing to disclose.
Margherita Daviddi	No disclosure on file
Tiffany Lago, MD	Dr. Lago has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Lago has stock in Sage Therapeutics.
Sara W. Hyman	Ms. Hyman has nothing to disclose.
Carter A. Bell	Mr. Bell has nothing to disclose.
Helena Digney, Other	Miss Digney has nothing to disclose.
James MacDougall	No disclosure on file
Kyra R. Steiner, MD	Ms. Steiner has nothing to disclose.
Suzan Moser, RN	Mrs. MOSER has stock in Medtronic. Mrs. MOSER has stock in Johnson and Johnson.
Birendra Sah	Birendra Sah has received publishing royalties from a publication relating to health care.
Dhivyaa Rajasundaram	Dhivyaa Rajasundaram has nothing to disclose.
Sharon Hammond-Heaton, RN	Ms. Hammond-Heaton has nothing to disclose.
Ibolya Boer, MD	Ibolya Boer has received personal compensation for serving as an employee of Novartis AG.
Brian Dewar	No disclosure on file
Dragos Manta	Dragos Manta has nothing to disclose.
Angie Goldsberry	No disclosure on file
Colin Meyer	No disclosure on file
Ethan Rich	No disclosure on file
Marcio Souza	Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.
Andreas Meier, MD	Dr. Meier has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Meier has received personal compensation for serving as an employee of Voyager Therapeutics. Dr. Meier has stock in Vigil Neuroscience. Dr. Meier has stock in Voyager Therapeutics.

��ɫ����

��ɫ����

��ɫ��

��ɫ��